Indian specialty-chemicals maker of advanced pharma and agrochemical intermediates, including contract manufacturing.
Indian specialty-chemicals maker of advanced pharma and agrochemical intermediates, including contract manufacturing.
Part of its income comes from making molecules to a customer's own specification, where the customer owns the design and Aether is paid for process development and production; the rest comes from its own intermediates sold to drug and crop-chemical makers. A few large customer launches can therefore carry much of the volume. It listed in 2022.
Moat: narrow (process know-how, IP / patents). Complex multi-step synthesis expertise for niche molecules, but Anupam Rasayan and others compete for the same CRAMS contracts.
Headquarters: Surat, India · Founded: 2013 · Employees: 1,449
Size Aether Industries (AETHER.NS) is an India Materials company (Chemicals: Major Diversified) with a market value of $2.34B, the 344th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹1,647 on 18 Nov 2026.
Performance Over six months the shares gained 50.3%, against -6.7% for the median peer and +3.8% for the India market (cap-weighted) — highest of 20 in its peer set.
Growth Revenue grew 30.8% over the last twelve months (peer median +7.7%); the operating margin is 25.3% (peer median 10.0%).
Valuation It trades at 76.6× forward earnings against a peer median of 20.2× (most expensive of 17).
Capital Return on invested capital runs 1.9 points below its cost of capital (9.4% WACC).
Next results Next results expected around 15 Jan 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹13.0B | ₹11.3B | ₹8.39B | ₹5.98B | ₹6.51B |
| Revenue growth | — | +35% | +40% | -8% | — |
| Gross profit | ₹4.88B | ₹3.22B | ₹2.38B | ₹1.47B | ₹2.19B |
| EBITDA | ₹4.06B | ₹3.39B | ₹2.44B | ₹1.34B | ₹1.90B |
| Net income | ₹2.49B | ₹2.19B | ₹1.58B | ₹825M | ₹1.30B |
| Free cash flow | n/a | -₹4.98B | -₹3.64B | -₹4.48B | -₹4.21B |
| Capital expenditure | n/a | ₹6.23B | ₹4.52B | ₹4.28B | ₹4.01B |
| Total debt | ₹6.75B | ₹4.58B | ₹2.00B | ₹1.83B | ₹157M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Aether Industries AETHER.NS | $2.34B | +50% | +31% | 25% | 76.6× | n/a |
| Anupam Rasayan India ANURAS.NS | $1.61B | -3% | +24% | 16% | 49.9× | n/a |
| Navin Fluorine International NAVINFLUOR.NS | $5.66B | +45% | +46% | 30% | 51.6× | 37.0% |
| Srf SRF.NS | $7.77B | -7% | +20% | 19% | 30.0× | 25.5% |
| Divi's Laboratories DIVISLAB.NS | $31.3B | +60% | +22% | 34% | 73.5× | 47.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | AETHER.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +8.3% | -6.9% | highest of 21 |
| 6-month return | +50.3% | -6.7% | highest of 20 |
| Distance from 52-week high | -9.2% | -22.9% | 4th highest of 21 |
| Revenue growth (TTM) | +30.8% | +7.7% | 5th highest of 21 |
| Operating margin | 25.3% | 10.0% | 2nd highest of 21 |
| Forward P/E | 76.6× | 20.2× | most expensive of 17 |
| ROIC minus cost of capital | -1.9 pp | +0.2 pp | 9th lowest of 21 |
| EV / EBITDA | 55.4× | 11.9× | most expensive of 14 |
| Net debt / EBITDA | 1.6× | 1.2× | 7th most indebted of 16 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Aether Industries AETHER.NS | India | $2.34B | +50% | +31% | 25% | 76.6× | n/a | n/a |
| Nippon Shokubai 4114.T | Japan | $2.24B | +16% | +8% | 6% | 17.4× | n/a | n/a |
| Hubei Sinophorus Electronic Materials 688545.SS | China | $2.07B | -39% | +75% | 11% | 62.9× | n/a | n/a |
| Grandit 688549.SS | China | $2.66B | -7% | +40% | -1% | n/a | n/a | n/a |
| Ingevity NGVT | United States | $1.97B | -12% | -12% | 26% | 10.2× | -1.4% | -0.8% |
| Eternal Materials 1717.TW | Taiwan | $1.96B | -29% | +7% | 6% | 14.8× | 14.5% | +1.2% |
| Innospec IOSP | United States | $1.94B | 0% | +5% | 8% | 13.8× | 5.0% | +8.3% |
| Advanced Echem Materials 4749.TWO | Taiwan | $1.93B | -34% | +20% | 25% | 33.6× | n/a | n/a |
| CES Energy Solutions CEU.TO | Canada | $2.92B | +5% | +17% | 11% | 13.5× | 9.1% | +22.9% |
| Zhejiang Yongtai Technology 002326.SZ | China | $1.81B | -44% | +38% | 11% | n/a | n/a | n/a |
| Fine Organic Industries FINEORG.NS | India | $1.81B | +21% | +13% | 20% | 33.4× | 28.7% | +15.7% |
| AARTI Industries AARTIIND.NS | India | $1.80B | -1% | +40% | 9% | 29.9× | n/a | n/a |
| Nippon Kayaku 4272.T | Japan | $1.71B | -9% | +16% | 10% | 10.5× | 1.7% | +6.9% |
| Alzchem ACT0.DE | Germany | $1.68B | n/a | +5% | 16% | 23.1× | 0.5% | +8.2% |
| Isuspecialtychemical 457190.KS | South Korea | $1.62B | -32% | +6% | 2% | n/a | n/a | n/a |
| Valiant 002643.SZ | China | $1.61B | -36% | +3% | 10% | 26.1× | 17.1% | +4.9% |
| Kuraray 3405.T | Japan | $3.41B | +14% | +7% | 10% | 14.1× | -5.0% | +8.3% |
| Huntsman HUN | United States | $1.58B | -36% | +6% | 0% | n/a | n/a | n/a |
| Borregaard BRG.OL | Norway | $1.58B | +6% | +3% | 17% | 24.0× | -1.2% | +7.7% |
| Johnson Matthey JMAT.L | United Kingdom | $3.76B | +6% | +8% | 3% | 12.9× | 9.2% | -4.0% |
| Privi Speciality Chemicals PRIVISCL.NS | India | $1.44B | +11% | +18% | 20% | 36.4× | 30.6% | +15.0% |